PowerShares KBW Bank ETF (KBWB) Forms $57.83 Double Top; Syros Pharmaceuticals (SYRS) Shorts Up By 4.86%

Syros Pharmaceuticals Inc (NASDAQ:SYRS) had an increase of 4.86% in short interest. SYRS’s SI was 2.58 million shares in March as released by FINRA. Its up 4.86% from 2.46M shares previously. With 353,200 avg volume, 7 days are for Syros Pharmaceuticals Inc (NASDAQ:SYRS)’s short sellers to cover SYRS’s short positions. The SI to Syros Pharmaceuticals Inc’s float is 17.02%. The stock increased 0.19% or $0.02 during the last trading session, reaching $10.45. About 266,201 shares traded. Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) has 0.00% since March 5, 2017 and is . It has underperformed by 16.70% the S&P500.

PowerShares KBW Bank ETF (KBWB) formed double top with $63.03 target or 9.00% above today’s $57.83 share price. PowerShares KBW Bank ETF (KBWB) has $1.25 billion valuation. The ETF increased 0.73% or $0.42 during the last trading session, reaching $57.83. About 223,718 shares traded. PowerShares KBW Bank ETF (NASDAQ:KBWB) has risen 31.59% since March 5, 2017 and is uptrending. It has outperformed by 14.89% the S&P500.

Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing treatments for cancer and immune-mediated diseases, and building a pipeline of gene control medicines. The company has market cap of $336.37 million. The Company’s lead drug candidates are SY-1425, a selective RARa agonist in a Phase 2 clinical trial for genomically defined subsets of patients with acute myeloid leukemia and myelodysplastic syndrome; and SY-1365, a selective CDK7 inhibitor with potential in a range of solid tumors and blood cancers. It currently has negative earnings. The firm was formerly known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012.